Using Artificial Intelligence for the Detection of Respiratory Diseases Associated With Pollution
Launched by UNIVERSITY OF MEDICINE AND PHARMACY "VICTOR BABES" TIMISOARA · Jul 15, 2024
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients must be diagnosed with COPD and/or asthma and/or pulmonary neoplasm and/or secondary pulmonary, pleural or mediastinal determinations, suspected or confirmed, according to ICD-10.
- • Patients will be included regardless of the type of hospitalization, continuous or day.
- • The existence of freely expressed consent, carried out according to Ethics standards professional (from the observation sheet).
- • For stage 2
- • The use of HRCT images, in DICOM format, with a maximum cup thickness of 1.5 mm and with an average of 250 cups; no image acquisition errors;
- • Imaging monitoring at a time interval;.
- • Respiratory function evaluation data available: spirometry +/- the factor of gaseous diffusion (DLco);
- Exclusion Criteria:
- For both stages:
- • - Patients who do not have a stable real domicile (eg social cases) or are not from the Timis county
- • For stage 2
- • Patients who do not have HRCT images available or cannot be followed.
- • Patients who have insufficient quality HRCT images.
- • Patients who have a history of lung surgery.
- • Patients who have a history of allergies to contrast agents used in imaging HRCT.
About University Of Medicine And Pharmacy "Victor Babes" Timisoara
The University of Medicine and Pharmacy "Victor Babeș" Timișoara is a prestigious educational and research institution located in Timișoara, Romania. Renowned for its commitment to advancing medical knowledge and healthcare practices, the university plays a pivotal role in clinical research, focusing on innovative treatments and methodologies. With a multidisciplinary approach, it fosters collaboration among medical professionals, researchers, and students, aiming to enhance patient care and contribute to the global medical community. The institution is dedicated to conducting high-quality clinical trials that adhere to rigorous ethical standards and regulatory guidelines, ultimately striving to improve health outcomes and foster scientific advancement.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Timisoara, Timis, Romania
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported